Market Exclusive

Analyst Downgrades – NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB) Stock Gets Downgraded By Chardan Capital from Buy to Neutral

Analyst Ratings For NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB)

Today, NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB) stock was downgraded by Chardan Capital from Buy to Neutral with a price target of $50.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB)
NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB) has insider ownership of 19.60% and institutional ownership of 76.81%.

Recent Trading Activity for NASDAQ:ASMB – Assembly Biosciences (NASDAQ:ASMB)
Shares of NASDAQ:ASMB – Assembly Biosciences closed the previous trading session at 44.49 down -4.08 8.40% with 44.130001068115234 shares trading hands.

Exit mobile version